Revenue calculator

Tirzepatide (GLP-1/GIP) Weight Management

Tirzepatide (Eli Lilly: Mounjaro / Zepbound) delivers stronger weight-loss outcomes than semaglutide. Compounded availability shifted in 2024 with FDA shortage resolution; market is in transition to branded-only programs with patient-pay programs.

Default projection5 new patients/month · national pricing · mid band · retail procurement

Year-1 revenue

$200,978

Ramp: 68%

Year-3 revenue

$503,332

Mature steady state

Year-1 gross profit

$100,489

Margin: 50.0%

Per-procedure price

$700

Mid band, national average

This is a starting scenario. Adjust volume, region, band, and procurement tier in the interactive builder.

Pricing

National-average price per per month. Regional adjustments apply: tier-1 metros are typically 20-50% above national.

Low

$450

Mid

$700

High

$1,050

  • Eli LillyEli Lilly product pricing and prescribing information (Mounjaro, Zepbound) link
  • American Med Spa Association (AmSpa)AmSpa State of the Medical Spa Industry Report 2025 link

Time, repeat cadence & retention

Returning appt

20 min

+ 5 min prep

New-patient appt

same

Repeat cadence

1 mo

Range 1-1 mo

Year-1 retention

55%

Y2 30% · Y3 18%

  • American Med Spa Association (AmSpa)AmSpa State of the Medical Spa Industry Report 2025 link
  • American Med Spa Association (AmSpa)AmSpa State of the Medical Spa Industry Report 2024 link

Procurement & cost of goods

Eli Lilly direct-pay pricing program brings branded vial cost into reach; compounded availability remains restricted.

COGS low

$200

COGS mid

$350

COGS high

$550

  • Eli LillyEli Lilly product pricing and prescribing information (Mounjaro, Zepbound) link

Provider scope

Who can perform this procedure (varies by state):

  • NP
  • PA
  • MD
  • DO

Patient-acquisition cost

Cost per acquired patient by channel (per-procedure-acquired-patient basis):

  • Paid ads$90 $220
  • Organic$22 $65
  • Referral$0 $40

Volume ramp curve

Fraction of mature monthly volume achievable at each month from launch.

Month 1

20%

Month 2

35%

Month 3

50%

Month 6

75%

Month 12

92%

Month 24

100%

  • American Med Spa Association (AmSpa)AmSpa State of the Medical Spa Industry Report 2025 link

Build a full P&L projection

Mix procedures, set regional pricing, model volume ramps, and project a full practice P&L.